NCT07503353 2026-03-31
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Not yet recruiting
Clinical Trials
9 trialsNCT07245381 2025-11-24
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT07162571 2025-09-09
MSTH-CAR002
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Not yet recruiting
NCT06602063 2025-06-27
Surgery for Relapsed Ovarian Cancer in Precision
Shanghai Gynecologic Oncology Group
Phase 1/2 Not yet recruiting
NCT06955390 2025-05-02
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06788197 2025-03-26
A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06454890 2024-06-12
Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06078670 2023-10-12
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting
NCT05882630 2023-05-31
Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting